Who is sponsoring NCT03942991?

NCT03942991 is sponsored by Cairo University.

What drugs are being tested in NCT03942991?

Interventions in NCT03942991: articaine, Mepivacaine 2% Injection.

What condition does NCT03942991 study?

NCT03942991 studies Badly Decayed Lower First Primary Molars in Children.

Is NCT03942991 still recruiting?

NCT03942991 is currently status unknown. Last updated 29 August 2019.

Last reviewed 2019-08-29 · How we verify

NCT03942991

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anesthetic Efficacy Of 4% ArtpharmaDent Versus 2% Mepecaine-L in Extraction of Lower First Primary Molars

Status unknown NA Last updated 29 August 2019

What this trial tests

NA trial testing articaine in Badly Decayed Lower First Primary Molars in Children in 20 participants. Status unknown.

Timeline

1 September 2019

Primary endpoint
1 November 2019

1 December 2019

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	20
Start date	1 September 2019
Primary completion	1 November 2019
Estimated completion	1 December 2019

Drugs / interventions tested

articaine (ARTICAINE) — full drug profile →
Mepivacaine 2% Injection — full drug profile →

Conditions studied

Badly Decayed Lower First Primary Molars in Children — all drugs for Badly Decayed Lower First Primary Molars in Children →

Sponsor

Cairo University

Who can join

Adults 6 to 8, any sex, with Badly Decayed Lower First Primary Molars in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

parallel technique will be done where the investigator (will be blinded) will give one type on anesthesia then performing the extraction and evaluating the intraoperative pain ,the same procedure will be done for the other type of anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03942991 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 29 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03942991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing